# A Comparative Study Between Lysine Clonixinate+Cyclobenzaprine and Caffeine+Carisoprodol+Sodium Diclofenac+Paracetamol

> **NCT01421433** · PHASE3 · UNKNOWN · sponsor: **Farmoquimica S.A.** · enrollment: 160 (estimated)

## Conditions studied

- Low Back Pain

## Interventions

- **DRUG:** Tandrilax
- **DRUG:** Dolamin Flex

## Key facts

- **NCT ID:** NCT01421433
- **Lead sponsor:** Farmoquimica S.A.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2012-05
- **Primary completion:** 2012-08
- **Final completion:** 2013-01
- **Target enrollment:** 160 (ESTIMATED)
- **Last updated:** 2012-03-08

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01421433

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01421433, "A Comparative Study Between Lysine Clonixinate+Cyclobenzaprine and Caffeine+Carisoprodol+Sodium Diclofenac+Paracetamol". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT01421433. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*